IRA-HSA_detail

The Inflation Reduction Act, HSAs and Insulin

08/23/2022 Written by: Patrick Haynes, Esq.

President Biden signed the Inflation Reduction Act of 2022 (IRA) into law on August 16, 2022.  See our link to the law and our blog entry below. 

While most of the IRA was focused on tax reform, climate change, and healthcare costs, there was a significant provision included that can be used to protect a taxpayer’s HSA (Health Savings Account), while also expanding coverage for insulin.

Please keep in mind that one of the eligibility rules for an HSA is that you may not enjoy any other first-dollar-coverage before satisfying your deductible.  Although, there is a limited exception (a safe harbor) for preventive care visits, prescriptions, etc.  In 2019, in IRS Notice 2019-45, the IRS described preventive care for chronic conditions that can be covered prior to satisfying the HDHP deductible—thus protecting/preserving an individual’s HSA.  We blogged about that at the time here.

The IRA expands and further codifies the IRS’ guidance by permitting an HDHP to cover “selected insulin” products prior to the deductible, without regard to whether the individual has been diagnosed with diabetes.  While IRC Section 223(c)(2)(C) states that preventive care is excluded as disqualifying first-dollar-coverage, the IRA defines “selected insulin products” as any dosage form (vial, pump, inhaler) or any type of insulin (short/rapid/intermediate/long/ultra-long-acting and premixed) and expands “preventive care” to include them (in general) as well as removing the diagnosis requirement.

When will this take effect?  For plan years beginning on or after December 31, 2022, HDHPs will be permitted to cover insulin for a broader range of uses than before—and they may do so prior to the plan participant meeting their deductible.  So, calendar year plans may adopt these changes for January 1, 2023.

 

Links:

Self-Funded Health Plans
The Power of Direct Contracting for Self-Funded Health Plans
Employee Benefits04/26/2024

Direct contracting is gaining traction as a financial tool for high-performing self-funded health plans to control claims costs and improve member care. Self-funded health plans, or a group of...

Wellness Programs
Capitalizing on Wellness
Employee Benefits04/23/2024

According to a recent report from Fortune Business Insights, the corporate wellness market was valued at $61 billion in 2023 and is expected to grow to over $82 billion by 2030. A thoughtfully...

Healthcare Analytics
Leveraging Healthcare Analytics to Revolutionize Your Benefits
Employee Benefits04/16/2024

The enhanced use of healthcare analytics is revolutionizing how employers are able to interpret data about their population that can aid in the successful evaluation and development of their employee...